FULL EVENT GUIDE
Having problems downloading?
Let us know here
Top 5 Unmissable Program Insights in 2024
- Delve into harmonizing omics phenotyping spanning genetic mutations, variations in gene expression and gene-environment interactions to dissect molecular drivers of variability and explore optimal stratification with Tenaya
- Leverage machine learning within large quantities of data to increase accuracy of risk identification for heart failure with Bayer
- Navigate the heterogeneity of heart failure through phenotyping and pathobiology with Novartis
- Streamline preclinical models from optimizing iPSCs, prioritizing human centric approaches and ensure robust in vivo modelling with Novo Nordisk & Pfizer
- Tackle aging associated changes to activin signaling and gene expression signatures and in the heart Regeneron
Companies on the Program
